Webster Bank’s Novo Nordisk NVO Stock Holding History

Webster Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$163K	Sell	3,402 -845	-20%	-$36.3K	0.01%	249
2026 Q1	$156K	Sell	4,247 -800	-16%	-$37.9K	0.01%	253
2025 Q4	$257K	Sell	5,047 -413	-8%	-$21.1K	0.02%	205
2025 Q3	$303K	Sell	5,460 -24,246	-82%	-$1.42M	0.03%	184
2025 Q2	$2.05M	Sell	29,706 -9,931	-25%	-$676K	0.21%	82
2025 Q1	$2.75M	Buy	39,637 +34,736	+709%	+$2.87M	0.3%	69
2024 Q4	$422K	Hold	4,901	–	–	0.05%	166
2024 Q3	$584K	Sell	4,901 -450	-8%	-$60K	0.06%	149
2024 Q2	$764K	Hold	5,351	–	–	0.08%	133
2024 Q1	$687K	Buy	5,351 +101	+2%	+$12K	0.08%	143
2023 Q4	$543K	Hold	5,250	–	–	0.07%	150
2023 Q3	$477K	Hold	5,250	–	–	0.06%	145
2023 Q2	$425K	Sell	5,250 -1,930	-27%	-$158K	0.05%	149
2023 Q1	$571K	Sell	7,180 -210	-3%	-$14.9K	0.07%	140
2022 Q4	$500K	Hold	7,390	–	–	0.07%	144
2022 Q3	$368K	Hold	7,390	–	–	0.05%	155
2022 Q2	$412K	Hold	7,390	–	–	0.06%	145
2022 Q1	$411K	Sell	7,390 -1,010	-12%	-$51.8K	0.05%	152
2021 Q4	$470K	Sell	8,400 -190	-2%	-$10.3K	0.05%	151
2021 Q3	$412K	Sell	8,590 -500	-6%	-$24.2K	0.05%	154
2021 Q2	$381K	Hold	9,090	–	–	0.04%	159
2021 Q1	$307K	Hold	9,090	–	–	0.04%	175
2020 Q4	$318K	Hold	9,090	–	–	0.04%	169
2020 Q3	$315K	Hold	9,090	–	–	0.04%	166
2020 Q2	$297K	Hold	9,090	–	–	0.04%	156
2020 Q1	$273K	Sell	9,090 -554	-6%	-$16.5K	0.05%	151
2019 Q4	$279K	Sell	9,644 -620	-6%	-$17.2K	0.04%	170
2019 Q3	$266K	Hold	10,264	–	–	0.04%	174
2019 Q2	$262K	Sell	10,264 -2,800	-21%	-$69.2K	0.04%	171
2019 Q1	$342K	Sell	13,064 -2,376	-15%	-$58.4K	0.05%	158
2018 Q4	$356K	Sell	15,440 -3,000	-16%	-$66.7K	0.06%	152
2018 Q3	$434K	Sell	18,440 -6,500	-26%	-$159K	0.06%	155
2018 Q2	$575K	Hold	24,940	–	–	0.08%	140
2018 Q1	$614K	Sell	24,940 -5,110	-17%	-$134K	0.09%	138
2017 Q4	$807K	Sell	30,050 -1,370	-4%	-$34.8K	0.11%	135
2017 Q3	$757K	Sell	31,420 -2,700	-8%	-$61K	0.11%	138
2017 Q2	$731K	Sell	34,120 -14,090	-29%	-$284K	0.11%	140
2017 Q1	$826K	Sell	48,210 -6,256	-11%	-$109K	0.12%	132
2016 Q4	$977K	Sell	54,466 -3,294	-6%	-$59.7K	0.14%	122
2016 Q3	$1.2M	Sell	57,760 -4,590	-7%	-$114K	0.17%	106
2016 Q2	$1.68M	Sell	62,350 -2,830	-4%	-$77.6K	0.25%	87
2016 Q1	$1.77M	Sell	65,180 -9,530	-13%	-$255K	0.28%	85
2015 Q4	$2.17M	Sell	74,710 -2,810	-4%	-$77.8K	0.35%	74
2015 Q3	$2.1M	Sell	77,520 -2,930	-4%	-$83K	0.39%	67
2015 Q2	$2.2M	Sell	80,450 -4,870	-6%	-$137K	0.37%	69
2015 Q1	$2.28M	Sell	85,320 -16,490	-16%	-$380K	0.38%	67
2014 Q4	$2.15M	Sell	101,810 -1,000	-1%	-$22.3K	0.36%	66
2014 Q3	$2.45M	Sell	102,810 -8,250	-7%	-$190K	0.43%	60
2014 Q2	$2.56M	Sell	111,060 -36,960	-25%	-$816K	0.44%	59
2014 Q1	$3.38M	Sell	148,020 -2,870	-2%	-$61.1K	0.47%	55
2013 Q4	$2.79M	Sell	150,890 -72,130	-32%	-$1.26M	0.39%	65
2013 Q3	$3.77M	Sell	223,020 -43,440	-16%	-$731K	0.58%	50
2013 Q2	$4.13M	Buy	+266,460	New	+$4.43M	0.52%	58

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Webster Bank's NVO Position: Q2 2026 in Review

Webster Bank reduced its Novo Nordisk (NVO) stake by 20% in Q2 2026, selling an estimated $36.3K and leaving 3,402 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #249.

Webster Bank first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.13M in Q2 2013. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Webster Bank held 3,402 shares of Novo Nordisk worth $163K as of Q2 2026.
Webster Bank sold 845 Novo Nordisk shares in Q2 2026, an estimated $36.3K.
Novo Nordisk made up 0.01% of Webster Bank's portfolio in Q2 2026, its #249 holding.
Webster Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
Webster Bank's Novo Nordisk position peaked at $4.13M in Q2 2013.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.